PTCT Stock Analysis: Buy, Sell, or Hold?
PTCT - PTC Therapeutics, Inc.
$75.53
-0.90 (-1.18%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
24d
Get Alerted When PTCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PTCT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PTCT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PTCT is currently trading at $75.53, which is considered slightly low relative to its 30-day fair value range of $74.96 to $77.89.
Technical Outlook: Technically, PTCT is in a strong uptrend. Immediate support is located at $69.81, while resistance sits at $78.38.
Market Sentiment: PTCT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $87.64 (+16.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PTCT is in a strong uptrend. Immediate support is located at $69.81, while resistance sits at $78.38.
Market Sentiment: PTCT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $87.64 (+16.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$74.96 -
$77.89
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
Protect Your Profits
Holding PTCT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($87.64)
Fair Price Analysis
30-Day Fair Range
$74.96 -
$77.89
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$69.81
Resistance Level
$78.38
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-82.64
Wall Street Target
$87.64
(+16.0%)
Revenue Growth (YoY)
7.2%
Profit Margin
42.2%
Last updated: February 01, 2026 1:20 AM ET
Data refreshes hourly during market hours. Next update: 2:20 AM
Data refreshes hourly during market hours. Next update: 2:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PTCT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark Elliott Boulding
SELL
3375 shares
2025-10-07
Mark Elliott Boulding
SELL
2266 shares
2025-10-06
Emma Reeve
SELL
25562 shares
2025-10-03
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced PTCT Option Strategies
Professional options setups generated by AI based on today's PTCT price and gamma walls.
